Evidence map›Paper›PMID 31967771›Full record

ArticleACS applied materials & interfaces2020

Fabrication and Characterization of Drug-Loaded Conductive Poly(glycerol sebacate)/Nanoparticle-Based Composite Patch for Myocardial Infarction Applications.

Nazanin Zanjanizadeh Ezazi, Rubina Ajdary, Alexandra Correia, Ermei Mäkilä, Jarno Salonen, Marianna Kemell, Jouni Hirvonen, Orlando J Rojas, Heikki J Ruskoaho, Hélder A Santos

Open access · hybridAbstract read
In one paragraph

Article in ACS applied materials & interfaces, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 82 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Nazanin Zanjanizadeh EzaziDrug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy , University of Helsinki , FI-00014 Helsinki , Finland.
Rubina AjdaryDepartment of Bioproducts and Biosystems, School of Chemical Engineering , Aalto University , P.O. Box 16300, FI-00076 Aalto , Espoo , Finland.
Alexandra CorreiaDrug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy , University of Helsinki , FI-00014 Helsinki , Finland.
Ermei MäkiläLaboratory of Industrial Physics, Department of Physics and Astronomy , University of Turku , FI-20014 Turku , Finland.ORCID http://orcid.org/0000-0002-8300-6533
Jarno SalonenLaboratory of Industrial Physics, Department of Physics and Astronomy , University of Turku , FI-20014 Turku , Finland.ORCID http://orcid.org/0000-0002-5245-742X
Marianna KemellDepartment of Chemistry , University of Helsinki , FI-00014 Helsinki , Finland.ORCID http://orcid.org/0000-0002-3583-2064
Jouni HirvonenDrug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy , University of Helsinki , FI-00014 Helsinki , Finland.
Orlando J RojasDepartment of Bioproducts and Biosystems, School of Chemical Engineering , Aalto University , P.O. Box 16300, FI-00076 Aalto , Espoo , Finland.ORCID http://orcid.org/0000-0003-4036-4020
Heikki J RuskoahoDrug Research Program, Division of Pharmacology and Pharmacotherapy , University of Helsinki , FI-00014 Helsinki , Finland.ORCID http://orcid.org/0000-0001-8971-1359
Hélder A SantosDrug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy , University of Helsinki , FI-00014 Helsinki , Finland.ORCID http://orcid.org/0000-0001-7850-6309
University of Helsinki · FIUniversity of Turku · FIAalto University · FIUniversity of British Columbia · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Heart tissue engineering is critical in the treatment of myocardial infarction, which may benefit from drug-releasing smart materials. In this study, we load a small molecule (3i-1000) in new biodegradable and conductive patches for application in infarcted myocardium. The composite patches consist of a biocompatible elastomer, poly(glycerol sebacate) (PGS), coupled with collagen type I, used to promote cell attachment. In addition, polypyrrole is incorporated because of its electrical conductivity and to induce cell signaling. Results from the in vitro experiments indicate a high density of cardiac myoblast cells attached on the patches, which stay viable for at least 1 month. The degradation of the patches does not show any cytotoxic effect, while 3i-1000 delivery induces cell proliferation. Conductive patches show high blood wettability and drug release, correlating with the rate of degradation of the PGS matrix. Together with the electrical conductivity and elongation characteristics, the developed biomaterial fits the mechanical, conductive, and biological demands required for cardiac treatment.

Indexed as

AnimalsDecanoatesDrug Delivery SystemsElectric ConductivityGlycerolHumansMaterials TestingMiceMyocardial InfarctionMyocytes, CardiacNanoparticlesPolymersPyrrolesSmall Molecule LibrariesDecanoatesGlycerolpoly(glycerol-sebacate)PolymerspolypyrrolePyrrolesSmall Molecule Librariesconductive polymersdrug deliveryheart tissue engineeringpolypyrroleregeneration

Identifiers

PMID31967771
PMCPMC7450488
OpenAlexW3002407685

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.